Follow The Filings

ACET Adicet Bio Inc.

Health Care, filed as ADICET BIO INC (COM NEW), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.2%
  • $811K

Who owns this now

Largest portfolio weights among holders, up to 0.2% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel 0.15%

Who owns ACET

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 0.15% Hold 93,812 $811K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ACET's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ACET insider trades
  • $1.6M bought by 1 insider
  • $675K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Ra Capital Management, L.P. 10% owner, +3 joint filers
    Buy
    $1.6M 223,596 shares at $7.17 +23% to stake
    Traded Feb 18–20 Filed Apr 13
    ↗
  2. Orbimed Advisors LLC 10% owner, +7 joint filers
    Sale
    $675K 104,658 shares at $6.45 100% of stake
    Traded Apr 7–8 Filed Apr 9
    ↗
  3. Orbimed Advisors LLC 10% owner, +7 joint filers
    Buy
    $5M 5,000,000 shares at $1.00 New stake
    Traded Oct 8, 2025 Filed Oct 10, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 4 share withholdings for taxes and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
10-K/A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 3.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated about 12 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$142.66M -$117.12M -$116.8M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $162.27M $180.14M $160.93M
Total non-current assets * $45.02M $40.08M $31.43M
Total assets $207.3M $220.22M $192.36M
Total current liabilities $19.29M $19.39M $21.53M
Total non-current liabilities * $17.83M $14.22M $11.61M
Total equity $170.18M $186.61M $159.21M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$93.72M -$92.38M -$95.25M
Cash from investing -$4.46M -$119.24M $2.39M
Cash from financing $0.236M $111.31M $75.24M
Net change in cash -$97.94M -$100.31M -$17.61M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf